| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |